Oncological resource allocation in Germany.
BACKGROUND
Oncology is a resource-intensive medical discipline where, so far, effectiveness rather than efficiency of a treatment has stood in the foreground. The aim of our study was, therefore, to determine the resource allocation and to assess the efficiency of oncology in Germany for the period of 2002-2004.


METHODS
With the aid of the official German Health Report, the expenditures for health in 2004 and the gain in years of life according to ICD 10 disease categories were analyzed. Based on the incremental costs and years of life gained, the cost calculation per year of life gained was made.


RESULTS
Malignant neoplasms appear in 5th place in health expenditures at a cost of 15 billion 1. With costs per year of life gained of 140,750 1, malignant neoplasms range ahead of respiratory diseases (52,500 1)digestive diseases (27,455 1), and injuries (14,538 1). Costs involving malignant neoplasm per year of life gained range between 39,000 1(malignancies of the lip, oral cavity, and the pharynx), and 126,000 1(digestive organ cancer).


CONCLUSIONS
In Germany, oncology incurs higher costs per year of life gained as compared to several other diseases. Also, in malignant neoplasm considerable differences can be observed regarding resource allocation and efficiency.
Hartmann
Michael
M
Faculty of Medicine, Friedrich-Schiller-University of Jena, Germany. Michael.Hartmann@med.uni-jena.de
Kath
Roland
R
Gundermann
Christin
C
D005858:Germany / Q000453:epidemiology; D017048:Health Care Costs / Q000706:statistics & numerical data*; D006801:Humans; D008495:Medical Oncology / Q000191:economics* / Q000706:statistics & numerical data; D009369:Neoplasms / Q000175:diagnosis / Q000191:economics* / Q000401:mortality* / Q000628:therapy; D015995:Prevalence; D040841:Resource Allocation / Q000191:economics* / Q000706:statistics & numerical data*; D016019:Survival Analysis; D015996:Survival Rate